Bayview Legacy, LLC, which holds a roughly ten percent stake in Arteris, Inc. (NASDAQ:AIP), executed the sale of 70,000 shares of Arteris common stock on April 8, 2026, according to a Form 4 filed with the Securities and Exchange Commission. The filing shows a weighted average sale price of $19.0398 per share, producing total proceeds of approximately $1.33 million. Reported trade prices for the block ranged from $18.67 to $19.43.
After the disposition, Bayview Legacy, LLC retains 9,119,071 shares of Arteris. The filing notes the sale was carried out pursuant to a 10b5-1 trading plan that K. Charles Janac, the manager of Bayview Legacy, established on March 5, 2025. Janac also submitted a separate Form 4 to disclose the same transaction, reflecting his beneficial ownership of the securities through his managerial control of Bayview Legacy.
The timing of the sale coincides with Arteris trading near its 52-week high of $19.85. Over the past 12 months the stock has risen roughly 190%. An InvestingPro assessment described in the filing material characterizes the shares as appearing overvalued at current market levels. The company carries a market valuation of $865 million, and its next scheduled earnings report is due in 21 days.
Recent company financials highlighted in filings show Arteris’ fourth-quarter 2025 results exceeded consensus expectations on both top-line and per-share metrics. Revenue for the quarter came in at $20.1 million versus an expected $18.55 million. Reported earnings per share were -$0.05, outperforming an anticipated -$0.07. The company’s earnings call emphasized these beats, and no mergers or acquisitions were disclosed in conjunction with the results.
The Form 4 disclosure and the company’s reported quarterly performance together give investors updated information on insider activity and recent operating results. The filing also notes that additional analytical content - including a set of ProTips and a Pro Research Report on Arteris - is available through InvestingPro for subscribers seeking deeper context.
Analyst coverage following the quarter has not produced recent upgrades or downgrades, according to the disclosure, and the company’s performance in upcoming quarters will be watched by investors seeking confirmation of the trajectory signaled by the latest results.
Quick facts
- Seller: Bayview Legacy, LLC (approximate 10% owner)
- Shares sold: 70,000
- Sale date: April 8, 2026
- Weighted average price: $19.0398
- Total proceeds: ~$1.33 million
- Price range for sales: $18.67 - $19.43
- Post-sale ownership: 9,119,071 shares
- 10b5-1 plan adoption date: March 5, 2025 (by K. Charles Janac, manager)
- Company valuation cited: $865 million
- Upcoming earnings: scheduled in 21 days